Overview of the regulation of the class IA PI3K/AKT pathway by SUMO

被引：26
|
作者：
Vidal, Santiago [1 ]
Bouzaher, Yanis Hichem [1 ]
El Motiam, Ahmed [1 ,2 ,3 ]
Seoane, Rocio [1 ]
Rivas, Carmen [1 ,4 ]
机构：
[1] Univ Santiago De Compostela, Ctr Invest Med Mol & Enfermedades Cronicas CIMUS, Inst Invest Sanit IDIS, Santiago De Compostela 15706, Spain
[2] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Dept Ophthalmol & Vis Sci,Sinai Hlth Syst, Toronto, ON M5G 1X5, Canada
[3] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada
[4] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada
来源：
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY | 2022年 / 132卷
关键词：
SUMO; PI3K; p85; p110; AKT; PTEN; NF-KAPPA-B; CELL-CYCLE PROGRESSION; PROTEIN-KINASE-B; E3; LIGASE; TUMOR-SUPPRESSOR; PHOSPHATIDYLINOSITOL; 3-KINASE; TYROSINE PHOSPHORYLATION; EMERGING MECHANISMS; RELA/P65; SUBUNIT; TOPORS FUNCTIONS;
D O I：
10.1016/j.semcdb.2021.10.012
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The phosphatidylinositol-3-kinase (PI3K)/AKT pathway is a major regulator of metabolism, migration, survival, proliferation, and antiviral immunity. Both an overactivation and an inhibition of the PI3K/AKT pathway are related to different pathologies. Activation of this signaling pathway is tightly controlled through a multistep process and its deregulation can be associated with aberrant post-translational modifications including SUMOylation. Here, we review the complex modulation of the PI3K/AKT pathway by SUMOylation and we discuss its putative incvolvement in human disease.
引用
收藏
页码：51 / 61
页数：11
相关论文
共 50 条
  • [21] The PI3K/Akt pathway: a critical player in intervertebral disc degeneration
    Ouyang, Zhi-Hua
    Wang, Wen-Jun
    Yan, Yi-Guo
    Wang, Bing
    Lv, Guo-Hua
    ONCOTARGET, 2017, 8 (34) : 57870 - 57881
  • [22] Multiple forms of cell death: A focus on the PI3K/AKT pathway
    Xu, Jiawei
    Li, Yu
    Kang, Meili
    Chang, Cuicui
    Wei, Hong
    Zhang, Chi
    Chen, Yuhua
    JOURNAL OF CELLULAR PHYSIOLOGY, 2023, 238 (09) : 2026 - 2038
  • [23] Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
    Jiang, Ningni
    Dai, Qijie
    Su, Xiaorui
    Fu, Jianjiang
    Feng, Xuancheng
    Peng, Juan
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (06) : 4587 - 4629
  • [24] Class IA PI3K isoforms lead to differential signalling downstream of PKB/Akt
    Catalak Yilmaz, Hazal B.
    Sulaiman, Mahnoor
    Isik, Ozlem Aybuke
    Cizmecioglu, Onur
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2024, 49 (02): : 210 - 219
  • [25] The role of PI3K/AKT/FOXO signaling in psoriasis
    Zhang, Miao
    Zhang, Xiaoyan
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2019, 311 (02) : 83 - 91
  • [26] Conjugation of SUMO to p85 leads to a novel mechanism of PI3K regulation
    de la Cruz-Herrera, C. F.
    Baz-Martinez, M.
    Lang, V.
    El Motiam, A.
    Barbazan, J.
    Couceiro, R.
    Abal, M.
    Vidal, A.
    Esteban, M.
    Munoz-Fontela, C.
    Nieto, A.
    Rodriguez, M. S.
    Collado, M.
    Rivas, C.
    ONCOGENE, 2016, 35 (22) : 2873 - 2880
  • [27] The PI3K Pathway: Background and Treatment Approaches
    Lux, Michael P.
    Fasching, Peter A.
    Schrauder, Michael G.
    Hein, Alexander
    Jud, Sebastian M.
    Rauh, Claudia
    Beckmann, Matthias W.
    BREAST CARE, 2016, 11 (06) : 398 - 404
  • [28] The PI3K/AKT/mTOR interactive pathway
    Ersahin, Tulin
    Tuncbag, Nurcan
    Cetin-Atalay, Rengul
    MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1946 - 1954
  • [29] PI3K/Akt signalling pathway and cancer
    Vara, JAF
    Casado, E
    de Castro, J
    Cejas, P
    Belda-Iniesta, C
    González-Barón, M
    CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
  • [30] Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
    Westin, Jason R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05) : 335 - 342
12345